SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chimerix, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - March 5, 2025) - Rigrodsky Law, P.A. is investigating Chimerix, Inc. ("Chimerix") (NASDAQ: CMRX) regarding possible breaches of fiduciary duties and other violations of law related to Chimerix's agreement to be acquired by Jazz Pharmaceuticals plc. Under the terms of the agreement, Chimerix shareholders will receive $8.55 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-chimerix-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243427

You May Also Be Interested In

• Boeing workers reject contract, authorize strike
• CoVolt Power files for proposed IPO
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices